Adakveo
Adakveo is a pharmaceutical brand.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Adakveo is a pharmaceutical brand. The available evidence confirms only its identity as a pharmaceutical brand; no further brand history, ownership, or product details are supported by the supplied snippets.
Recent events
FDA approves Adakveo for sickle cell disease pain crises[1]
Reported:
The FDA approved crizanlizumab (Adakveo, Novartis) to reduce the frequency of pain crises among people with sickle cell disease; the article states it is indicated for patients aged 16 or older.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/adakveo · Editorial policy · How profiles are compiled